Technology Holding, LLC
Salt Lake City, UT · Biotech · Private
monoclonal antibodies against antibiotic-resistant bacterial infections
- Grants
- $20M
- 29 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Agriculture · Novel Process For Production Of Fatty Acids From Lignocellulosic Biomass | $99,997 | |
| Federal grant | Department of Agriculture · Novel Process For Production Of Fatty Acids From Lignocellulosic Biomass | $449,959 | |
| Federal grant | Department of Energy · Phase I · Novel Process for Biomass Conversion to Methyl Butanols | $224,973 | |
| Federal grant | Department of Defense · Phase I · Biomimetic Material Solutions for the Stabilization of Labile Reagents | $149,999 | |
| Federal grant | Department of Defense · Phase II · Novel Bioprocess for Spider Silk Fiber Production | $563,150 | |
| Federal grant | Department of Energy · Phase II · Novel Process for Biomass Conversion to 5 Carbon Alcohols | $1,499,990 | |
| Federal grant | Department of Defense · Phase II · Biomimetic Material Solutions for the Stabilization of Labile Reagents | $749,972 | |
| Federal grant | Department of Defense · Phase I · Novel Method for Production of High Energy Density Fuel | $124,997 | |
| Federal grant | Department of Defense · Phase I · Engineered Strain for Bioconversion of Food Waste to Fuels | $150,000 | |
| Federal grant | Department of Defense · Phase I · Informatics Driven Discovery and Design of Deep Eutectic Solvents and Nanomaterials based Supercapacitors for Enhanced Low-temperature Performance | $95,466 | |
| Federal grant | Department of Defense · Phase II · Reproducible high yield production of structural proteins for biologically-derived fibers as an alternative to nylon | $999,534 | |
| Federal grant | Department of Energy · Phase II · Novel Process for Biomass Conversion to 5 Carbon Alcohols | $1,000,000 | |
| Federal grant· 1 of 2 same day | Department of Energy · Phase I · Nanoporous Atomically Thin Membranes for Desalination and Rare Earth Materials Recovery | $200,000 | |
| Federal grant· 2 of 2 same day | Department of Energy · Phase I · Novel Modular GTL Reactor | $200,000 | |
| Federal grant | Department of Defense · Phase I · Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE) | $167,499 | |
| Federal grant | Department of Defense · Phase II · Portable Ruggedized Energy Efficient Medical Sterilizer for Field Use | $1,311,316 | |
| Federal grant | Department of Energy · Phase II · Modular Gas to Chemicals Reactor | $1,149,998 | |
| Federal grant | Department of Defense · Phase I · Novel Biologic Countermeasure for Acute Radiation Syndrome | $249,971 | |
| Federal grant | Department of Defense · Phase I · Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection | $249,563 | |
| Federal grant | Department of Energy · Phase I · Novel Syn Bio Method to Produce Performance Advantaged Polymers | $249,994 | |
| Federal grant | Department of Defense · Phase II · Novel Honeycomb Hollow Carbon Fiber Composite | $750,000 | |
| Federal grant | Department of Defense · Phase II · Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE) | $541,247 | |
| Federal grant | Department of Defense · Phase I · Autonomous Biomanufacturing at Remote Locations | $225,000 | |
| Federal grant | Department of Energy · Phase II · Novel Syn Bio Method to Produce Performance Advantaged Polymers | $1,650,000 | |
| Federal grant | Department of Defense · Phase II · Novel Biologic Countermeasure for Acute Radiation Syndrome | $2,999,994 | |
| Federal grant | Department of Defense · Phase II · Development of Human Monoclonal Antibody Therapeutic Against Klebsiella pneumoniae Infection | $1,099,026 | |
| Federal grant | Department of Defense · Phase I · Novel Method for Renewable JP10 Production | $139,852 | |
| Federal grant | Department of Defense · Phase II · Innovative Method for Development of Hemp based Fabric | $1,001,437 | |
| Federal grant | Department of Defense · Phase II · Autonomous Manufacturing at Remote Locations | $1,478,293 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3089 | Verismo Therapeutics, Inc. | — | $63M |
| 3090 | SYNLIBRIS, INC. | — | — |
| 3091 | ZETTA AI, LLC | — | — |
| 3092 | Technology Holding, LLC | — | — |
| 3093 | MADELEINE PHARMACEUTICALS, INC. | — | — |
| 3094 | AGYPHARMA, LLC | — | — |
| 3095 | TINY CARGO COMPANY, THE | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Producing 1,8-DIHYDROXYNAPHTHALENE And Cyclic Hydrocarbons From 1,8-DIHYDROXYNAPHTHALENEapplication
- Method for Production of Bicyclic Hydrocarbonapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.